The decision-making process in prostate cancer screening in primary care with a prostate-specific antigen: A systematic review

Journal of Geriatric Oncology

Volumn 2, Issue 3, 2011, Pages 161-176

  Vedel, Isabelle ^a,b   Puts, Martine T E ^a,c   Monette, Michele ^a   Monette, Johanne ^a,d   Bergman, Howard ^a,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer screening; Early detection of cancer; Primary care; Primary care physician; Prostate cancer; Systematic review

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AWARENESS; CANCER SCREENING; DIAGNOSTIC TEST; DOCTOR PATIENT RELATION; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; PROFESSIONAL KNOWLEDGE; PROSTATE CANCER; RESPONSIBILITY; REVIEW; SYSTEMATIC REVIEW; WORK ENVIRONMENT;

EID: 79958724156     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2011.04.001     Document Type: Review

References (59)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Schroder F.H., Hugosson J., Roobol M.J., Tammela T.L., Ciatto S., Nelen V., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009, 360(13):1320-1328.
3. Andriole G.L., Crawford E.D., Grubb R.L., Buys S.S., Chia D., Church T.R., et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009, 360(13):1310-1319.
4. Pinsky P.F., Blacka A., Kramer B.S., Miller A., Prorok P.C., Berg C. Assessing contamination and compliance in the prostate component of the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Clin Trials 2010, 7(4):303-311.
5. Carroll P., Albertsen P.C., Greene K., Babaian R.J., Carter H.B., Gann P.H., et al. Prostate-specific antigen best practice statement: 2009 update 2009.
6. Heidenreich A., Bolla M., Joniau S., Mason M.D., Matveev V., Mottet N., et al. Guidelines on prostate cancer 2010.
7. Draisma G., Etzioni R., Tsodikov A., Mariotto A., Wever E., Gulati R., et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009, 101(6):374-383.
8. Hoffman K.E., Nguyen P.L., Ng A.K., D'Amico A.V. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy. J Urol 2010, 183(5):1798-1802.
9. Walter L.C., Bertenthal D., Lindquist K., Konety B.R. PSA screening among elderly men with limited life expectancies. JAMA 2006, 296(19):2336-2342.
10. Kilpelainen TP, Tammela TL, Maattanen L, Kujala P, Stenman UH, Ala-Opas M, et al. False-positive screening results in the Finnish prostate cancer screening trial. Br J Cancer;102(3):469-74.
11. Barry M.J. Screening for prostate cancer - the controversy that refuses to die. N Engl J Med 2009, 360(13):1351-1354.
12. Newman D.H. Screening for breast and prostate cancers: moving toward transparency. J Natl Cancer Inst 2010, 102(14):1008-1011.
13. Recommendations for clinical preventive services http://www.ahrq.gov/clinic/prevenix.htm.
14. The UK NSC policy on Prostate cancer screening/PSA testing in men over the age of 50 2010. http://www.screening.nhs.uk/prostatecancer.
15. Opportunité d'un dépistage systématique de la prostate par le dosage de l'antigène spécifique de la prostate http://www.has-sante.fr/portail/upload/docs/application/pdf/psa4p.pdf.
16. Wolf A.M., Wender R.C., Etzioni R.B., Thompson I.M., D'Amico A.V., Volk R.J., et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010, 60(2):70-98.
17. Konety B.R., Cooperberg M.R., Carroll P.R. Are age-based criteria the best way to determine eligibility for prostate cancer screening?. Ann Intern Med 2009, 150(3):220-221.
18. Gogol M. Are age-based criteria the best way to determine eligibility for prostate cancer screening?. Ann Intern Med 2009, 150(3):221.
19. Sheinfeld Gorin S., Gauthier J., Hay J., Miles A., Wardle J. Cancer screening and aging: research barriers and opportunities. Cancer Dec 15 2008, 113(12 Suppl):3493-3504.
20. Rodgers M., Sowden A., Petticrew M., Arai L., Roberts H., Britten N., et al. Testing methodological guidance on the conduct of narrative synthesis in systematic review: effectiveness of interventions to promote smoke alarm ownership and function. Evaluation 2009, 15:49-73.
21. SUMARI. System for the unified management, assessment and review of information http://www.joannabriggs.edu.au/pdf/sumari_user_guide.pdf.
22. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008, 61(4):344-349.
23. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012.
24. Little B., Ho K.J., Gormley G., Young M. PSA testing in general practice. Prostate Cancer Prostatic Dis 2003, 6(2):154-158.
25. Brett J., Watson E., Hewitson P., Bukach C., Edwards A., Elwyn G., et al. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK. BMC Fam Pract 2005, 6(1):24.
26. Pendleton J., Whit Curry R., Kaserian A., Chang M., Anai S., Nakamura K., et al. Knowledge and attitudes of primary care physicians regarding prostate cancer screening. J Med Assoc 2008, 100(6):666-670.
27. Linder S.K., Hawley S.T., Cooper C.P., Scholl L.E., Jibaja-Weiss M., Volk R.J. Primary care physicians' reported use of pre-screening discussions for prostate cancer screening: a cross-sectionnal survey. BMC Fam Pract 2009, 10:19.
28. Curran V., Solberg S., Mathews M., Church J., Buehler S., Wells J., et al. Prostate cancer screening attitudes and continuing education needs of primary care physicians. J Cancer Educ 2005, 20(3):162-166.
29. Durham J., Low M., McLeod D. Screening for prostate cancer: a survey of New Zealand general practitioners. [See comment]. N Z Med J 2003, 116(1176):U476.
30. Jonler M., Eddy B., Poulsen J. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark. Scand J Urol Nephrol 2005, 39(3):214-218.
31. Kim H.L., Benson D.A., Stern S.D., Gerber G.S. Practice trends in the management of prostate disease by family practice physicians and general internists: an internet-based survey. Urology 2002, 59(2):266-271.
32. Praz V., Jichlinski P., Aymon D., Leisinger H.J. Screening of the prostate cancer. "Instantaneous" of a daily practice among 300 general practitioners of the canton of Vaud. [French]. Rev Med Suisse 2005, 1(44):2840-2842.
33. Sorum P.C., Shim J., Chasseigne G., Bonnin-Scaon S., Cogneau J., Mullet E. Why do primary care physicians in the United States and France order prostate-specific antigen tests for asymptomatic patients?. Med Decis Making 2003, 23(4):301-313.
34. Voss J.D., Schectman J.M. Prostate cancer screening practices and beliefs. J Gen Intern Med 2001, 16(12):831-837.
35. Philips G.K., Reinier K., Ashikaga T., Luebbers R.A. Attitudes and beliefs of primary care physicians regarding prostate and colorectal cancer screening in a rural state. J Cancer Educ 2005, 20(3):167-172.
36. Ganry O., Boche T. Prevention practices and cancer screening among general practitioners in Picardy (France). Bull Cancer 2004, 10:785-791. [French].
37. Gany F., Trinh-Shevrin C., Aragones A. Cancer screening and Haitian immigrants: the primary care provider factor. J Immigr Minor Health 2008, 3:255-261.
38. Jacobsen P.B., Lamonde L.A., Honour M., Kash K., Hudson P.B., Pow-Sang J. Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psychooncology 2004, 13(2):80-85.
39. Parchment Y.D. Prostate cancer screening in African American and Caribbean males: detriment in delay. ABNF J 2004, 15(6):116-120.
40. Steele C.B., Miller D.S., Maylahn C., Uhler R.J., Baker C.T. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health 2000, 90(10):1595-1600.
41. Lewis C.L., Kistler C.E., Amick H.R., Watson L.C., Bynum D.L., Walter L.C., et al. Older adults' attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities. BMC Geriatr 2006, 6:10.
42. Cormier L., Reid K., Kwan L., Litwin M.S. Screening behavior in brothers and sons of men with prostate cancer. J Urol 2003, 169(5):1715-1719.
43. Gattellari M., Ward J.E. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial. J Med Screen 2003, 10(1):27-39.
44. Hoffman R.M., Couper M.P., Zikmund-Fisher B.J., Levin C.A., McNaughton-Collins M., Helitzer D.L., et al. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study). Arch Intern Med 2009, 169(17):1611-1618.
45. Davis S.N., Diefenbach M.A., Valdimarsdottir H., Chen T., Hall S.J., Thompson H.S. Pros and cons of prostate cancer screening: associations with screening knowledge and attitudes among urban African American men. J Natl Med Assoc 2010, 102(3):174-182.
46. Watson E., Hewitson P., Brett J., Bukach C., Evans R., Edwards A., et al. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested. Patient Educ Couns 2006, 63(3):367-379.
47. Frosch D.L., Kaplan R.M., Felitti V.J. A randomized controlled trial comparing internet and video to facilitate patient education for men considering the prostate specific antigen test. J Gen Intern Med 2003, 18(10):781-787.
48. Gattellari M., Ward J.E. A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Patient Educ Couns 2005, 57(2):168-182.
49. Evans R., Elwyn G., Edwards A., Newcombe R., Kinnersley P., Wright P., et al. A randomised controlled trial of the effects of a web-based PSA decision aid, Prosdex. Protocol. BMC Fam Pract 2007, 8:58.
50. Walter L.C., Covinsky K.E. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001, 285(21):2750-2756.
51. Lafortune L., Beland F., Bergman H., Ankri J. Health state profiles and service utilization in community-living elderly. Med Care 2009, 47(3):286-294.
52. Lo A., Ryder K., Shorr R.I. Relationship between patient age and duration of physician visit in ambulatory setting: does one size fit all?. J Am Geriatr Soc 2005, 53(7):1162-1167.
53. Bynum J., Song Y., Fisher E. Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare. J Am Geriatr Soc 2010, 58(4):674-680.
54. Crabtree B.F., Nutting P.A., Miller W.L., Stange K.C., Stewart E.E., Jaen C.R. Summary of the National Demonstration Project and recommendations for the patient-centered medical home. Ann Fam Med 2010, 8(Suppl 1):S80-S90. [S92].
55. Jaen C.R., Ferrer R.L., Miller W.L., Palmer R.F., Wood R., Davila M., et al. Patient outcomes at 26 months in the patient-centered medical home National Demonstration Project. Ann Fam Med 2010, 8(Suppl 1):S57-S67. [S92].
56. Boult C., Green A.F., Boult L.B., Pacala J.T., Snyder C., Leff B. Successful models of comprehensive care for older adults with chronic conditions: evidence for the Institute of Medicine's "retooling for an aging America" report. J Am Geriatr Soc 2009, 57(12):2328-2337.
57. Hopkins S.C., Lenz E.R., Pontes N.M., Lin S.X., Mundinger M.O. Context of care or provider training: the impact on preventive screening practices. Prev Med Jun 2005, 40(6):718-724.
58. Keleher H., Parker R., Abdulwadud O., Francis K. Systematic review of the effectiveness of primary care nursing. Int J Nurs Pract 2009, 15(1):16-24.
59. Hudson S.V., Ohman-Strickland P., Ferrante J.M., Lu-Yao G., Orzano A.J., Crabtree B.F. Prostate-specific antigen testing among the elderly in community-based family medicine practices. J Am Board Fam Med 2009, 22(3):257-265.